Novel Drug Combination Shows Promising Results in HER2-Positive Metastatic Breast Cancer: Pyrotinib and Etoposide
*💡 What's This About?* A new study published in BMC Cancer examined an innovative combination of two drugs - Pyrotinib and *Etoposide* in metronomic dosing (low continuous dosing) in patients…